Preliminary Phase 1/1b Dose Expansion Results of the Bifunctional EGFR/TGFβ Inhibitor Ficerafusp Alfa (BCA101) with Pembrolizumab in Patients with Squamous Cell Carcinoma of the Anal Canal.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined